Integra LifeSciences IART Change in AP
Change in AP at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's change in ap.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Integra LifeSciences's change in AP?
- Integra LifeSciences (IART) reported change in AP of -$19.19M in Q1 2026.
- How has Integra LifeSciences's change in AP changed year-over-year?
- Integra LifeSciences's change in AP decreased by 6.6% year-over-year, from -$18M to -$19.19M.
- What is the long-term trend for Integra LifeSciences's change in AP?
- Over 3 years (2021 to 2025), Integra LifeSciences's change in AP has grown at a -7.6% compound annual growth rate (CAGR), from $33.86M to $26.72M.
- What does change in AP mean?
- Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.